Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenge Li

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Nature Communications|May 21, 2015
The oncogenic microRNA miR-21 promotes regulated necrosis in miceXiaodong Ma, Daniel J Conklin, Fenge Li, et al.
Carbohydrate Research|January 4, 2015
Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavityElizabeth S DeLyria, Dapeng Zhou, Jun Soo Lee, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 16, 2020
Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibitionQizhen Cao, Wanqin Wang, Min Zhou, et al.
Cancer Immunology Research|March 22, 2015
BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of MelanomaSherille D Bradley, Zeming Chen, Brenda Melendez, et al.
Nature Immunology|March 27, 2012
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone lossMehmet A Eskan, Ravi Jotwani, Toshiharu Abe, et al.
Cell Reports|August 30, 2018
Rapid and Integrative Discovery of Retina Regulatory MoleculesNicholas E Albrecht, Jonathan Alevy, Danye Jiang, et al.
PNAS Nexus|August 25, 2022
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I moleculesKyle R Jackson, Dinler A Antunes, Amjad H Talukder, et al.
Nature Communications|October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancersSherille D Bradley, Amjad H Talukder, Ivy Lai, et al.
Journal for Immunotherapy of Cancer|July 10, 2021
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutationsFenge Li, Ligang Deng, Kyle R Jackson, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Nature Communications|May 21, 2015
The oncogenic microRNA miR-21 promotes regulated necrosis in miceXiaodong Ma, Daniel J Conklin, Fenge Li, et al.
Carbohydrate Research|January 4, 2015
Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavityElizabeth S DeLyria, Dapeng Zhou, Jun Soo Lee, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 16, 2020
Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibitionQizhen Cao, Wanqin Wang, Min Zhou, et al.
Cancer Immunology Research|March 22, 2015
BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of MelanomaSherille D Bradley, Zeming Chen, Brenda Melendez, et al.
Nature Immunology|March 27, 2012
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone lossMehmet A Eskan, Ravi Jotwani, Toshiharu Abe, et al.
Cell Reports|August 30, 2018
Rapid and Integrative Discovery of Retina Regulatory MoleculesNicholas E Albrecht, Jonathan Alevy, Danye Jiang, et al.
PNAS Nexus|August 25, 2022
Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I moleculesKyle R Jackson, Dinler A Antunes, Amjad H Talukder, et al.
Nature Communications|October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancersSherille D Bradley, Amjad H Talukder, Ivy Lai, et al.
Journal for Immunotherapy of Cancer|July 10, 2021
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutationsFenge Li, Ligang Deng, Kyle R Jackson, et al.
Pageof 9